Ara
Toplam kayıt 2, listelenen: 1-2
Febril Nötropeni Gelişim Riski Olan ve Granülosit Koloni Stimüle Edici Faktör (G-Csf) Kullanan Kanser Hastalarının Patıent Rısk Score (Prs) ile Takibi ve Yan Etkilerinin Değerlendirilmesi
(Sağlık Bilimleri Enstitüsü, 2018-06)
Febrile neutropenia is the most important dose-limiting side effect of chemotherapy. Although the international treatment guidelines recommend prophylactic use of G-CSF in chemotherapy protocols with a risk of febrile ...
Yenidoğan Hastalarda İlaç Kaynaklı Sorunlar
(Sağlık Bilimleri Enstitüsü, 2022-11-01)
The higher rate of drug-related problems (DRPs) in hospitalized neonates is associated with the diversity of prescribed drugs and differences in age, weight and diagnosis. The aims of this study were (i) to perform risk ...